TabletAnti Diabetic

Dapagliflozin + Sitagliptin + Metformin

Dapagliflozin + Sitagliptin + Metformin Hydrochloride · SGLT2 inhibitor, DPP-4 inhibitor and biguanide antidiabetic combination

TabletAnti Diabetic

Dapagliflozin + Sitagliptin + MetforminProspero Healthcare

This tablet contains Dapagliflozin + Sitagliptin + Metformin Hydrochloride and belongs to the group of SGLT2 inhibitor, DPP-4 inhibitor and biguanide antidiabetic combination products. It is used in the management of type 2 diabetes mellitus, in line with standard clinical indications for this class.

Uses

Type 2 diabetes mellitus

Enquire about this product

Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.

01Specification

Product details

Composition: Dapagliflozin + Sitagliptin + Metformin Hydrochloride
Dosage form: Tablet
Therapeutic category: Anti Diabetic
Therapeutic class: SGLT2 inhibitor, DPP-4 inhibitor and biguanide antidiabetic combination
Packing: 10 × 10 tablets in blister / Alu-Alu strips
Storage: Store below 30 °C, protected from light and moisture.

02Related

From the same category

View the category